These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3762597)

  • 21. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
    McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
    Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compliance difficulties with progestin-supplemented estrogen replacement therapy.
    Hahn RG; Nachtigall RD; Davies TC
    J Fam Pract; 1984 Mar; 18(3):411-4. PubMed ID: 6699581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and progestin supplementation.
    Nurse Pract; 1995 Mar; 20(3):63-6. PubMed ID: 7761042
    [No Abstract]   [Full Text] [Related]  

  • 24. Initial treatment of dysfunctional uterine bleeding with estrogen--progestin combination.
    Mansuwan K
    J Med Assoc Thai; 1980 Jan; 63(1):6-10. PubMed ID: 7359057
    [No Abstract]   [Full Text] [Related]  

  • 25. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HRT dosing regimens: continuous versus cyclic-pros and cons.
    Shoupe D
    Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2003; 10(6):497-506. PubMed ID: 14627857
    [No Abstract]   [Full Text] [Related]  

  • 28. A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids.
    Sherwin BB; Gelfand MM
    Obstet Gynecol; 1989 May; 73(5 Pt 1):759-66. PubMed ID: 2704504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pros and cons of estrogen-replacement therapy.
    Quigley MM; Hammond CB
    N Engl J Med; 1980 Jan; 302(5):297. PubMed ID: 7350488
    [No Abstract]   [Full Text] [Related]  

  • 30. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 31. How progestins prevent endometrial cancer.
    Siddle NC
    Rev Fr Gynecol Obstet; 1985 Mar; 80(4):219-21. PubMed ID: 3992123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of progestogens in postmenopausal women.
    Gambrell RD
    Int J Fertil; 1989; 34(5):315-21. PubMed ID: 2571591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helping women stop postmenopausal hormone therapy.
    Grady D
    Menopause; 2006; 13(3):323-4. PubMed ID: 16735925
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pros and cons of estrogen-replacement therapy.
    Korenman SG
    N Engl J Med; 1980 Jan; 302(5):297. PubMed ID: 7350487
    [No Abstract]   [Full Text] [Related]  

  • 39. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
    Seifert-Klauss V; Kingwell E; Hitchcock CL; Kalyan S; Prior JC
    Menopause; 2008; 15(1):203; author reply 203-4. PubMed ID: 18182940
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.
    Weinstein L
    Obstet Gynecol; 1987 Jun; 69(6):929-32. PubMed ID: 3574823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.